Owens & Minor, Inc. Common Stock (NY:OMI)

2.800 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Owens & Minor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stocks Pare Losses After Trump Pauses Mexico Tariffs ↗

February 03, 2025

Stocks are lower midday, but have pared much steeper premarket losses, after U.S. President Trump paused tariffs on Mexico for one month.

Via Talk Markets

Topics Government Stocks / Equities World Trade

Owens & Minor Stock Dips On Mixed Q4 Preliminary Results & $310 Million Apria Goodwill Charge: Details ↗

February 03, 2025

Owens & Minor shares dipped after disclosing preliminary results and financing for the Rotech Healthcare Holdings, Inc. buyout. The company expects to close the deal in the first half of 2025 and sees...

Via Benzinga

Owens & Minor Launches Financing for Rotech Acquisition and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Results Ahead of Investor Meetings

February 03, 2025

From Owens & Minor, Inc.

Via Business Wire

Owens & Minor to Present at Upcoming Investor Conferences

December 02, 2024

From Owens & Minor

Via Business Wire

Analyst Ratings For Owens & Minor ↗

November 05, 2024

Via Benzinga

Looking Into Owens & Minor's Recent Short Interest ↗

July 11, 2024

Via Benzinga

$100 Invested In Owens & Minor 5 Years Ago Would Be Worth This Much Today ↗

July 09, 2024

Via Benzinga

Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 05, 2024

Via Benzinga

Health Solutions Provider Owens & Minor's Q3 Earnings: Revenue And EPS Beat, Trims Annual Outlook ↗

November 04, 2024

Owens & Minor Q3 2024 highlights include a 5% sales increase to $2.72 billion, adjusted EPS of $0.42, and Patient Direct revenue growth led by diabetes and sleep supplies.

Via Benzinga

Owens & Minor Reports Third Quarter 2024 Financial Results

November 04, 2024

From Owens & Minor, Inc.

Via Business Wire

Owens & Minor Announces Third Quarter 2024 Earnings Release Date and Conference Call

October 21, 2024

From Owens & Minor, Inc.

Via Business Wire

Owens & Minor Names Jonathan Leon Executive Vice President, Chief Financial Officer

September 23, 2024

From Owens & Minor

Via Business Wire

Cardinal Health, Inc. Dividend Stock Analysis ↗

September 13, 2024

Cardinal Health Inc. is one of the leading wholesale distributors of pharmaceuticals, medical/surgical supplies and related products to a broad range of health care customers.

Via Talk Markets

Owens & Minor Announces New Partnership with Google Cloud

September 10, 2024

From Owens & Minor, Inc.

Via Business Wire

Owens & Minor to Present at the 2024 Baird Global Healthcare Conference

September 09, 2024

From Owens & Minor

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Iris Energy, and DexCom and Encourages Investors to Contact the Firm

August 19, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm

August 05, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

OMI Stock Earnings: Owens & Minor Beats EPS, Beats Revenue for Q2 2024 ↗

August 02, 2024

OMI stock results show that Owens & Minor beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Healthcare Logistics Provider Owens & Minor Calls Q2 Performance Consistent With Expectations, Reiterates Annual Guidance ↗

August 02, 2024

Owens & Minor reported Q2 2024 adjusted EPS of $0.36, beating consensus. Sales rose to $2.671 billion, driven by growth in diabetes and sleep supplies. The company reaffirms 2024 revenue guidance of...

Via Benzinga

Owens & Minor Reports Second Quarter 2024 Financial Results

August 02, 2024

From Owens & Minor, Inc.

Via Business Wire

OMI Investors Have Opportunity to Join Owens & Minor, Inc. Fraud Investigation with the Schall Law Firm

August 01, 2024

From The Schall Law Firm

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Five Below and Encourages Investors to Contact the Firm

July 27, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Healthcare Logistics Service Firm Owens & Minor To Buy Home-Based Care Equipment Firm For $1.4B, Sees Better Than Expected Q2 Earnings ↗

July 23, 2024

Owens & Minor is set to acquire Rotech Healthcare for $1.36 billion, enhancing its Patient Direct segment and aiming for $5 billion in revenue by 2028. The deal includes anticipated tax benefits and...

Via Benzinga

Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 23, 2024

Via Benzinga

Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday ↗

July 23, 2024

Via Benzinga

Owens & Minor, Inc. Releases Preliminary Second Quarter 2024 Financial Results & Reaffirms 2024 Annual Guidance

July 23, 2024

From Owens & Minor, Inc.

Via Business Wire

Owens & Minor, Inc. Signs Definitive Agreement to Acquire Rotech Healthcare Holdings, Inc. for $1.36 Billion in Cash

July 23, 2024

From Owens & Minor, Inc.

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Target Hospitality, Owens & Minor, and Salesforce and Encourages Investors to Contact the Firm

July 19, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 16, 2024

Via Benzinga

Top 5 Health Care Stocks That May Explode In July ↗

July 08, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.